About MVM Life Science Partners

MVM manages four funds totaling more than US$700 million. MVM has invested in biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare services, medical devices, OTC medicines, research tools and vaccines.

Investment Details

Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Life Science, Foodtech, Hardware (+2 more)
Investor Type
Venture Capital

Investment Focus

Focus Areas
Foodtech Hardware Healthcare VR/AR Life Science +1 more
Investment Stages
Debt, Early Stage Venture, Late Stage Venture, Venture